Bolt Biotherapeutics (BOLT) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
BOLT is expected to report earnings to fall 21.88% to -31 cents per share on March 26
Q4'24
Est.
$-0.31
Q3'24
Missed
by $0.06
Q2'24
Missed
by $0.10
Q1'24
Beat
by $0.23
Q4'23
Est.
$-0.47
The last earnings report on November 13 showed earnings per share of -40 cents, missing the estimate of -34 cents. With 377.48K shares outstanding, the current market capitalization sits at 21.64M.